172 related articles for article (PubMed ID: 31899533)
1. Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.
Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
JAMA Netw Open; 2020 Jan; 3(1):e1918586. PubMed ID: 31899533
[TBL] [Abstract][Full Text] [Related]
2. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.
Keating NL; Huskamp HA; Schrag D; McWilliams JM; McNeil BJ; Landon BE; Chernew ME; Normand ST
Med Care; 2018 Jan; 56(1):69-77. PubMed ID: 29135615
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Practice Patterns Among Oncologists Participating in the Oncology Care Model.
Walker B; Frytak J; Hayes J; Neubauer M; Robert N; Wilfong L
JAMA Netw Open; 2020 May; 3(5):e205165. PubMed ID: 32421185
[TBL] [Abstract][Full Text] [Related]
4. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
[TBL] [Abstract][Full Text] [Related]
5. Variation in Physician Spending and Association With Patient Outcomes.
Tsugawa Y; Jha AK; Newhouse JP; Zaslavsky AM; Jena AB
JAMA Intern Med; 2017 May; 177(5):675-682. PubMed ID: 28288254
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
7. Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients.
Dean EB; Johnson P; Bond AM
JAMA Netw Open; 2021 Jan; 4(1):e2034776. PubMed ID: 33502485
[TBL] [Abstract][Full Text] [Related]
8. Influence of Peer Physicians on Intensity of End-of-Life Care for Cancer Decedents.
Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
Med Care; 2019 Jun; 57(6):468-474. PubMed ID: 31008900
[TBL] [Abstract][Full Text] [Related]
9. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Hospital Mortality and Readmission Rates for Medicare Patients Treated by Male vs Female Physicians.
Tsugawa Y; Jena AB; Figueroa JF; Orav EJ; Blumenthal DM; Jha AK
JAMA Intern Med; 2017 Feb; 177(2):206-213. PubMed ID: 27992617
[TBL] [Abstract][Full Text] [Related]
11. The impact of integration on outpatient chemotherapy use and spending in Medicare.
Jung J; Feldman R; Kalidindi Y
Health Econ; 2019 Apr; 28(4):517-528. PubMed ID: 30695812
[TBL] [Abstract][Full Text] [Related]
12. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
Wilson LE; Pollack CE; Greiner MA; Dinan MA
Breast Cancer Res Treat; 2018 Jul; 170(2):361-371. PubMed ID: 29536319
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Hospital Resource Use and Outcomes Among Hospitalists, Primary Care Physicians, and Other Generalists.
Stevens JP; Nyweide DJ; Maresh S; Hatfield LA; Howell MD; Landon BE
JAMA Intern Med; 2017 Dec; 177(12):1781-1787. PubMed ID: 29131897
[TBL] [Abstract][Full Text] [Related]
14. Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay.
Zipkin R; Schaefer A; Chamberlin M; Onega T; O'Malley AJ; Moen EL
Cancer Med; 2021 Feb; 10(4):1253-1263. PubMed ID: 33455068
[TBL] [Abstract][Full Text] [Related]
15. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Adams JR; Elting LS; Lyman GH; George JN; Lembersky BC; Armitage JO; Demetri GD; Bennett CL
Am J Med; 2004 Jan; 116(1):28-34. PubMed ID: 14706663
[TBL] [Abstract][Full Text] [Related]
16. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States.
Erie JC; Barkmeier AJ; Hodge DO; Mahr MA
Ophthalmology; 2016 Jun; 123(6):1257-62. PubMed ID: 26976701
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Physician Variation in Provision of Low-Value Services.
Schwartz AL; Jena AB; Zaslavsky AM; McWilliams JM
JAMA Intern Med; 2019 Jan; 179(1):16-25. PubMed ID: 30508010
[TBL] [Abstract][Full Text] [Related]
18. Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries.
Chen C; Petterson S; Phillips R; Bazemore A; Mullan F
JAMA; 2014 Dec; 312(22):2385-93. PubMed ID: 25490329
[TBL] [Abstract][Full Text] [Related]
19. Medical oncologists' perceptions of financial incentives in cancer care.
Malin JL; Weeks JC; Potosky AL; Hornbrook MC; Keating NL
J Clin Oncol; 2013 Feb; 31(5):530-5. PubMed ID: 23269996
[TBL] [Abstract][Full Text] [Related]
20. Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting.
Lipitz-Snyderman A; Atoria CL; Schleicher SM; Bach PB; Panageas KS
J Oncol Pract; 2019 Jan; 15(1):e30-e38. PubMed ID: 30543762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
